![Eugeen Vanmechelen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eugeen Vanmechelen
Founder at ADx NeuroSciences NV
Eugeen Vanmechelen active positions
Companies | Position | Start | End |
---|---|---|---|
ADx NeuroSciences NV
![]() ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Chief Tech/Sci/R&D Officer | 2010-12-31 | - |
Founder | 2010-12-31 | - |
Career history of Eugeen Vanmechelen
Training of Eugeen Vanmechelen
Ghent University | Undergraduate Degree |
Statistics
International
Belgium | 3 |
Operational
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
ADx NeuroSciences NV
![]() ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Health Technology |
- Stock Market
- Insiders
- Eugeen Vanmechelen
- Experience